Bumper Offer - Urjas oil Just @ Rs. 1
Zifi 400 Tablet (10), a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Ear Infection, Tonsillitis, Bronchitis. Secondary and off-label uses of Zifi 400 Tablet (10) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Zifi 400 Tablet (10). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Zifi 400 Tablet (10) as well, which are listed below. These side effects of Zifi 400 Tablet (10) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Zifi 400 Tablet (10)'s effect is Safe during pregnancy and Safe for lactating mothers. Warnings related to Zifi 400 Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Zifi 400 Tablet (10) have been discussed in the sections ahead.
Besides this, Zifi 400 Tablet (10) may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Zifi 400 Tablet (10), it is important to know that it is not safe while driving, and is not habit-forming.
Zifi 400 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Female) |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Zifi 400 Tablet (10) safe for pregnant women?
Zifi is safe to take during pregnancy.
Is the use of Zifi 400 Tablet (10) safe during breastfeeding?
Zifi is completely safe for breastfeeding women.
What is the effect of Zifi 400 Tablet (10) on the Kidneys?
Zifi has very mild side effects on the kidneys.
What is the effect of Zifi 400 Tablet (10) on the Liver?
Zifi is not harmful for the liver.
What is the effect of Zifi 400 Tablet (10) on the Heart?
You can take Zifi without any fear of damage to the heart.
Zifi 400 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zifi 400 Tablet (10) unless your doctor advises you to do so -
Is this Zifi 400 Tablet (10) habit forming or addictive?
No, you will not get addicted to Zifi 400 Tablet (10).
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Zifi 400 Tablet (10) as you may feel sleepy.
Is it safe?
Zifi 400 Tablet (10) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Zifi 400 Tablet (10) in mental disorders is not effective.
Interaction between Food and Zifi 400 Tablet (10)
Taking Zifi 400 Tablet (10) with food does not cause any problems.
Interaction between Alcohol and Zifi 400 Tablet (10)
It is difficult to say anything about the effect of Zifi 400 Tablet (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
